TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 294 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q1 2023. The put-call ratio across all filers is 0.29 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $720,341 | +65.2% | 43,710 | +30.1% | 0.00% | – |
| Q3 2022 | $436,000 | -31.3% | 33,601 | -25.8% | 0.00% | – |
| Q2 2022 | $635,000 | -11.4% | 45,259 | -9.6% | 0.00% | – |
| Q1 2022 | $717,000 | -35.1% | 50,065 | -22.0% | 0.00% | – |
| Q3 2019 | $1,105,000 | -5.6% | 64,209 | -2.9% | 0.00% | – |
| Q2 2019 | $1,171,000 | -17.4% | 66,143 | -4.9% | 0.00% | – |
| Q1 2019 | $1,417,000 | – | 69,557 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bartlett & Co. LLC | 20,781 | $296 | 0.01% |
| Valued Wealth Advisors LLC | 231 | $3,574 | 0.00% |
| BALDWIN BROTHERS LLC/MA | 2,035 | $29,039 | 0.00% |